Predictors of immune-related adverse events and outcomes in patients with NSCLC treated with immune-checkpoint inhibitors

Objective To identify predictors of immune-related adverse events (IRAEs) in patients with non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICIs). Assess associations between outcomes and the development of IRAEs.Methods Retrospective analysis of patients with NSCLC trea...

ver descrição completa

Detalhes bibliográficos

Principais autores:	M. Serino, C. Freitas, M. Martins, P. Ferreira, C. Cardoso, F. Veiga, V. Santos, D. Araújo, H. Novais-Bastos, A. Magalhães, H. Queiroga, G. Fernandes, V. Hespanhol
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Taylor & Francis Group 2024-07-01
coleção:	Pulmonology
Assuntos:	NSCLC immune checkpoint Inhibitors Immune-related adverse events outcomes
Acesso em linha:	https://www.tandfonline.com/doi/10.1016/j.pulmoe.2022.03.003
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!